Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Buprenorphin

Evaluation of the effects of a monthly buprenorphine depot subcutaneous injection on qt interval during treatment for opioid use disorder.

Evaluation of the effects of a monthly buprenorphine depot subcutaneous injection on qt interval during treatment for opioid use disorder.

Schmith VD, Curd L, Lohmer LRL, Laffont CM, Andorn A, Young MA.

Clin Pharmacol Ther. 2019 Feb 22. doi: 10.1002/cpt.1406. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30801681